BRD4 and neoplasm: Unexpectedly, RCAN1.4 gene expression is driven by super-enhancers in breast cancer cells, and suppression of super-enhancer activity with BRD4 knockdown or BRD4 inhibitor treatment reduces RCAN1.4 tumor suppressor gene expression [32].